Novavax
stock was climbing Tuesday after the company announced that an initial one million doses of its Covid-19 vaccine are now available for use in the U.K.
Shares of
Novavax
(ticker: NVAX) have struggled this year, tumbling 86% so far in 2022, and 90% in the past 12 months. The company slashed its full-year revenue guidance back in August, and posted a disappointing second quarter amid poor demand for its Covid-19 vaccine.
Last week Microsoft Israel, the local marketing and sales office of the US software giant, announced the departure of...
Mohit Malhotra, Global CEO, Dabur India Dabur India posted a consolidated net profit of ₹362 crore in the March quarter,...
Quick Read Jim Cramer said no to Applied Digital (APLD) despite its $7.5 billion CoreWeave contract, arguing the company is...
Kevin Warsh, U.S. President Donald Trump's pick to lead the Federal Reserve, cleared a key procedural hurdle on Wednesday, opening...
By Saad Sayeed, Ariba Shahid and Steve Holland ISLAMABAD/WASHINGTON, April 25 (Reuters) - Iranian Foreign Minister Abbas Araqchi laid out...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
